The Envirocleanse mission is to provide the world with a sustainable biocide. The patent-pending technology behind Envirocleanse was brought to the forefront by Dr. Phil Bellan as a means to fight infection in wounds. In late 2015, Charter Brokerage, a BERKSHIRE HATHAWAY unit, bought Envirocleanse to increase its size and scope. The flagship of Envirocleanse is the EPA-registered disinfectant known as Envirocleanse-A (the “A” stands for Anolite). The Envirocleanse-A solution is hypochlorous acid (HOCl), a nontoxic, non-corrosive biodegradable disinfectant. To find out more, please contact one of our listed team members.
| Website | https://www.envirocleanse.us/ |
| Employees | 12 (6 on RocketReach) |
| Founded | 2015 |
| Phone | +1 713-840-0404 |
| Industry | Biotechnology Research |
| Keywords | Disinfection, Antimicrobial, Infection Control, Wound Care, Biotechnology, Green Technology, Environmental Technology, Sustainable Technology, Patented Technology, Clean Technology, Medical Technology, Healthcare Technology, Infection Prevention, Sterilization, Sanitization, Hygiene, Biosafety, Decontamination |
| Competitors | BASF, Ecolab, ABM Industries, Sealed Air Corporation, Diversey Nederland, Kimberly-Clark Professional, Bunzl UK and Ireland, SC Johnson Professional UK, P&G Professional, Clorox Professional Products Company +40 more (view full list) |
Looking for a particular Envirocleanse employee's phone or email?
Kevin Paglino is the COO of Envirocleanse.
6 people are employed at Envirocleanse.